Company intelligence / Profile preview

ELITechGroup

France

Ownership: Private
Employees: ~600
Development stage: Other

Overview

ELITechGroup has commercialized a broad suite of molecular diagnostics, microbiology, and biomedical systems products (not drugs), with leading proprietary real-time PCR assay technology for infectious and genetic disease diagnosis. Their results are adopted in >100 countries and known for superior sensitivity and specificity in molecular diagnostics.

Therapeutic areas: ImmunologyInfectious DiseasesRare DiseasesOncology
Modalities: DeviceReagentSoftware
Industry: Molecular Diagnostics

Partnerships

OEM partnerships with IVD companiesDistribution partnerships (Biogenuix in India)

Beyond the preview

Go deeper on ELITechGroup.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ELITechGroup.

Explore the full profile